Contact
searchSearch
HMP Global

Case Reports

Case Report
Left Atrial Myxoma: Immediate Presentation, Diagnosis, and Treatment
03/20/2026
Richard Casazza, MAS; Neel Patel, MD; Allan Mattia, MD; Paul Saunders, MD; Arsalan Hashmi, MD; Greg Ribakove, MD
Cardiac myxomas are histologically benign tumors; however, they may lead to life-threatening complications. The authors share the case of a successful removal of myxoma with resolution of the patient's symptoms.
Cardiac myxomas are histologically benign tumors; however, they may lead to life-threatening complications. The authors share the case of a successful removal of myxoma with resolution of the patient's symptoms.
Cardiac myxomas are...
03/20/2026
Cath Lab Digest
Case Report
Treating Chronic Venous Disease With a Modified Gun-Sight Technique  
03/16/2026
Matthew A. Tiede, MD
Dr. Tiede describes using a modified gun-sight recanalization approach to reconstruct an absent/occluded common femoral vein in a patient with severe chronic venous disease. A step-by-step discussion of the gun-sight technique is available in...
Dr. Tiede describes using a modified gun-sight recanalization approach to reconstruct an absent/occluded common femoral vein in a patient with severe chronic venous disease. A step-by-step discussion of the gun-sight technique is available in...
Dr. Tiede describes using a...
03/16/2026
Cath Lab Digest
Case Report
Bracing for the Unseen: Navigating the Unpredictable in Heart Failure
03/15/2026
Muhammad Imran Hanif, MBBS, FCPS, FSCAI, FRCP; Minahil Tariq Sheikh, MBBS, FCPS
Hanif and Sheikh report a dramatic heart failure presentation caused by an acutely ruptured sinus of Valsalva aneurysm with right-atrial shunting. It was successfully treated in the cath lab with transcatheter closure using an Amplatzer Duct...
Hanif and Sheikh report a dramatic heart failure presentation caused by an acutely ruptured sinus of Valsalva aneurysm with right-atrial shunting. It was successfully treated in the cath lab with transcatheter closure using an Amplatzer Duct...
Hanif and Sheikh report a...
03/15/2026
Cath Lab Digest
Peripheral Interventions
Recalcitrant Total Occlusion of the Superficial Femoral Artery: Image-Guided Stent Placement
01/28/2026
Ivana Kumar; Kusum Lata, MD, FACC, FSCAI; Anshita Kumari, MBBS
The authors report a case of recurrent superficial femoral artery occlusion that necessitated the use of endovascular intervention with image-guided stent placement.
The authors report a case of recurrent superficial femoral artery occlusion that necessitated the use of endovascular intervention with image-guided stent placement.
The authors report a case of...
01/28/2026
Cath Lab Digest
Case Report
Eventration of the Diaphragm Presenting as Unstable Angina: The Importance of Looking at Non-Cardiac Findings on Catheterization Cines
01/23/2026
Saiyeda S. Ali, MD; Greeshma Molugu, MD; Ruben Abreu, MD; Asad Rizvi, MD; Mehdi Khalafi, MD
A 56-year-old male with a past medical history of gastroesophageal reflux disease and tobacco abuse presented to the emergency department with a chief complaint of chest pain and progressive shortness of breath of a year duration. The patient...
A 56-year-old male with a past medical history of gastroesophageal reflux disease and tobacco abuse presented to the emergency department with a chief complaint of chest pain and progressive shortness of breath of a year duration. The patient...
A 56-year-old male with a past...
01/23/2026
Cath Lab Digest
Case Report
The Invisible Revealed: The Importance of IVUS in Diagnosing and Treating a Coronary Wire Complication
01/05/2026
Muhammad Imran Hanif, MBBS, FCPS, FSCAI, FRCP; Muhammad Sikandar Saleem, MBBS, FCPS; Muhammad Ansar Maqsood, MBBS, FCPS
The authors share a case of complex wire entrapment during left anterior descending percutaneous coronary intervention illustrating the role of intravascular ultrasound in directing a bailout strategy.
The authors share a case of complex wire entrapment during left anterior descending percutaneous coronary intervention illustrating the role of intravascular ultrasound in directing a bailout strategy.
The authors share a case of...
01/05/2026
Cath Lab Digest
Case Report
Eighty Years Undetected: A Congenital Coronary Cameral Fistula Without Significant Shunt
12/16/2025
Abdul Wahab, MD; Sachin Joseph, MD; Andres Vargas-Estrada, MD
The authors share a case of a large LAD-to-right-sided coronary cameral fistula that produced angiographic coronary steal but no significant shunt, allowing for successful conservative management.
The authors share a case of a large LAD-to-right-sided coronary cameral fistula that produced angiographic coronary steal but no significant shunt, allowing for successful conservative management.
The authors share a case of a...
12/16/2025
Cath Lab Digest
Case Report
Successful Coil Embolization of Bleeding Facial Artery in a Patient With Facial Trauma
12/14/2025
Mehmet Cilingiroglu, MD; Ibrahim Halil Inanc, MD
Maxillofacial injury is common following major facial trauma, and can lead to life-threatening hemorrhage. The branches of the external carotid artery (Figure 1) are most vulnerable to trauma as the vessels transverse bone structures. The...
Maxillofacial injury is common following major facial trauma, and can lead to life-threatening hemorrhage. The branches of the external carotid artery (Figure 1) are most vulnerable to trauma as the vessels transverse bone structures. The...
Maxillofacial injury is common...
12/14/2025
Cath Lab Digest
Case Report
Percutaneous Ventricular Septal Defect (VSD) Closure in a Postinfarct VSD: Better Lucky Than Good!
12/05/2025
Neeraj N. Shah, MD, MPH; Dennis Phillips, DO; Hiroyuki Tsukui, MD; Mitsugu Ogawa, MD; Fouad Jabbour, MD; Ashwin Thiagarajasubramanian, MD; Juan Chahin, MD
Postinfarct (PI) ventricular septal defect (VSD) usually occurs 2-7 days after untreated acute myocardial infarction (MI) due to interventricular septal rupture after necrosis. In the current era of primary percutaneous coronary intervention...
Postinfarct (PI) ventricular septal defect (VSD) usually occurs 2-7 days after untreated acute myocardial infarction (MI) due to interventricular septal rupture after necrosis. In the current era of primary percutaneous coronary intervention...
Postinfarct (PI) ventricular...
12/05/2025
Cath Lab Digest
Case Report
When All Else Fails: Devices to Optimize PCI in Calcified and Tortuous Vessels
11/01/2025
Boskey Patel, DO, FACC, FSCAI
Calcified coronary lesions remain a formidable opponent in the cath lab, despite the many advancements made in the field to overcome the challenges they pose. Fortunately, operators have an ever-evolving arsenal of interventional tools to...
Calcified coronary lesions remain a formidable opponent in the cath lab, despite the many advancements made in the field to overcome the challenges they pose. Fortunately, operators have an ever-evolving arsenal of interventional tools to...
Calcified coronary lesions...
11/01/2025
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

Device Longevity
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
05/05/2026
The COMMENCE trial provides prospective, 10-year data demonstrating the durability of Edwards’ RESILIA tissue and its role in lifetime management for patients with aortic stenosis.
The COMMENCE trial provides prospective, 10-year data demonstrating the durability of Edwards’ RESILIA tissue and its role in lifetime management for patients with aortic stenosis.
The COMMENCE trial provides...
05/05/2026
Cath Lab Digest
Stroke
Newly Published Study Shows Sensome Clot-Sensing Guidewire Accurately Reveals True Clot Make-Up in Fully Occluded Brain Vessels for First Time
05/05/2026
By integrating the world’s smallest electrical impedance sensor with predictive algorithms into a standard 0.014” guidewire, the Clotild clot-sensing guidewire is designed to provide physicians with real-time, in situ biological intelligence...
By integrating the world’s smallest electrical impedance sensor with predictive algorithms into a standard 0.014” guidewire, the Clotild clot-sensing guidewire is designed to provide physicians with real-time, in situ biological intelligence...
By integrating the world’s...
05/05/2026
Cath Lab Digest
Non-Obstructive HCM
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Non-Obstructive Hypertrophic Cardiomyopathy
05/05/2026
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. -- Cytokinetics, Incorporated announced positive topline results from ACACIA-HCM (Assessment Comparing Aficamten to Placebo on Cardiac Endpoints In Adults with Non-Obstructive HCM), the pivotal Phase 3...
SOUTH SAN FRANCISCO, Calif. --...
05/05/2026
Cath Lab Digest
Mechanical Circulatory Support
Promising Data from US Pilot Study Shows Planned Impella 5.5 Use is Safe and Feasible in Non-Shock, High-Risk Cardiac Surgery Patients
05/05/2026
Chicago, IL – Johnson & Johnson announced results from a novel U.S. pilot single-arm trial that evaluated the safety and feasibility of planned Impella 5.5™ support in adult patients undergoing cardiac surgery in the setting of...
Chicago, IL – Johnson & Johnson announced results from a novel U.S. pilot single-arm trial that evaluated the safety and feasibility of planned Impella 5.5™ support in adult patients undergoing cardiac surgery in the setting of...
Chicago, IL – Johnson &...
05/05/2026
Cath Lab Digest
Drug-Eluting Balloons
Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan 
04/30/2026
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical...
04/30/2026
Cath Lab Digest
J. Dawn Abbott, MD, MSCAI
society news
SCAI Announces J. Dawn Abbott, MD, MSCAI, President for 2026–27
04/30/2026
Dr. Abbott is a nationally recognized leader in interventional cardiology, serving as Professor of Medicine and Director of Interventional Cardiology and the Cardiac Catheterization Laboratories at Brown University Health Cardiovascular...
Dr. Abbott is a nationally recognized leader in interventional cardiology, serving as Professor of Medicine and Director of Interventional Cardiology and the Cardiac Catheterization Laboratories at Brown University Health Cardiovascular...
Dr. Abbott is a nationally...
04/30/2026
Cath Lab Digest
Below-Ankle Intervention
Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle
04/29/2026
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy...
04/29/2026
Vascular Disease Management
Optical Coherence Tomography
Abbott Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 AI-Powered Coronary Imaging Platform
04/28/2026
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery   The integrated imaging...
Ultreon 3.0 is the first advanced optical coherence tomography (OCT) system in the U.S. and Europe that integrates high resolution coronary plaque images and AI-automated insights through the artery   The integrated imaging...
Ultreon 3.0 is the first...
04/28/2026
Cath Lab Digest
CoraFlex and CoraForce microcatheters (Reflow Medical)
Microcatheters
Reflow Medical Announces U.S. Launch of Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters
04/24/2026
Designed for complex coronary interventions, the Cora Torqueable Microcatheters introduce enhancements focused on spinning freedom and torque transmission, supporting controlled navigation and lesion crossing in challenging anatomies.
Designed for complex coronary interventions, the Cora Torqueable Microcatheters introduce enhancements focused on spinning freedom and torque transmission, supporting controlled navigation and lesion crossing in challenging anatomies.
Designed for complex coronary...
04/24/2026
Cath Lab Digest
GLP-1 Medications
New Study Links GLP-1 Medications to Lower Risk of Atrial Fibrillation, Independent of Weight Loss
04/23/2026
Researchers conducted a single-center retrospective study of 13,034 patients who initiated GLP-1-RA therapy between January 2020 and May 2024.
Researchers conducted a single-center retrospective study of 13,034 patients who initiated GLP-1-RA therapy between January 2020 and May 2024.
Researchers conducted a...
04/23/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use